Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1994 Jun;75(3):147–155.

Towards an understanding of Wilms' tumour.

K A Williamson 1, V Van Heyningen 1
PMCID: PMC2001799  PMID: 8086311

Abstract

Many areas of research are contributing to our understanding of WT and the role of WT1 in development of the renal and genitourinary systems. Characterization of putative target genes and the control of their expression continues. The importance of isoform ratios and imprinting effects are also under active investigation, often using animal models. The accumulating mutation data, together with evolutionary studies, illuminate WT1 structure-function relationships, highlighting the regions critical in normal development and tumorigenesis. And last, but by no means least, the hunt for the WT2 and WT3 genes continues.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird P. N., Groves N., Haber D. A., Housman D. E., Cowell J. K. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene. 1992 Nov;7(11):2141–2149. [PubMed] [Google Scholar]
  2. Baird P. N., Santos A., Groves N., Jadresic L., Cowell J. K. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet. 1992 Aug;1(5):301–305. doi: 10.1093/hmg/1.5.301. [DOI] [PubMed] [Google Scholar]
  3. Barlow D. P., Stöger R., Herrmann B. G., Saito K., Schweifer N. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature. 1991 Jan 3;349(6304):84–87. doi: 10.1038/349084a0. [DOI] [PubMed] [Google Scholar]
  4. Beckwith J. B., Kiviat N. B., Bonadio J. F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol. 1990;10(1-2):1–36. doi: 10.3109/15513819009067094. [DOI] [PubMed] [Google Scholar]
  5. Bickmore W. A., Oghene K., Little M. H., Seawright A., van Heyningen V., Hastie N. D. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science. 1992 Jul 10;257(5067):235–237. doi: 10.1126/science.1321494. [DOI] [PubMed] [Google Scholar]
  6. Brenner B., Wildhardt G., Schneider S., Royer-Pokora B. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene. 1992 Jul;7(7):1431–1433. [PubMed] [Google Scholar]
  7. Breslow N., Beckwith J. B., Ciol M., Sharples K. Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res. 1988 Mar 15;48(6):1653–1657. [PubMed] [Google Scholar]
  8. Brown K. W., Watson J. E., Poirier V., Mott M. G., Berry P. J., Maitland N. J. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient. Oncogene. 1992 Apr;7(4):763–768. [PubMed] [Google Scholar]
  9. Bruening W., Bardeesy N., Silverman B. L., Cohn R. A., Machin G. A., Aronson A. J., Housman D., Pelletier J. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet. 1992 May;1(2):144–148. doi: 10.1038/ng0592-144. [DOI] [PubMed] [Google Scholar]
  10. Call K. M., Glaser T., Ito C. Y., Buckler A. J., Pelletier J., Haber D. A., Rose E. A., Kral A., Yeger H., Lewis W. H. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990 Feb 9;60(3):509–520. doi: 10.1016/0092-8674(90)90601-a. [DOI] [PubMed] [Google Scholar]
  11. Christy B., Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8737–8741. doi: 10.1073/pnas.86.22.8737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Coppes M. J., Bonetta L., Huang A., Hoban P., Chilton-MacNeill S., Campbell C. E., Weksberg R., Yeger H., Reeve A. E., Williams B. R. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer. 1992 Nov;5(4):326–334. doi: 10.1002/gcc.2870050408. [DOI] [PubMed] [Google Scholar]
  13. Coppes M. J., Liefers G. J., Higuchi M., Zinn A. B., Balfe J. W., Williams B. R. Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res. 1992 Nov 1;52(21):6125–6128. [PubMed] [Google Scholar]
  14. Coppes M. J., Liefers G. J., Paul P., Yeger H., Williams B. R. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1416–1419. doi: 10.1073/pnas.90.4.1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cowell J. K., Wadey R. B., Haber D. A., Call K. M., Housman D. E., Pritchard J. Structural rearrangements of the WT1 gene in Wilms' tumour cells. Oncogene. 1991 Apr;6(4):595–599. [PubMed] [Google Scholar]
  16. Davis L. M., Stallard R., Thomas G. H., Couillin P., Junien C., Nowak N. J., Shows T. B. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci. Science. 1988 Aug 12;241(4867):840–842. doi: 10.1126/science.2841760. [DOI] [PubMed] [Google Scholar]
  17. DeChiara T. M., Robertson E. J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991 Feb 22;64(4):849–859. doi: 10.1016/0092-8674(91)90513-x. [DOI] [PubMed] [Google Scholar]
  18. Douglass E. C., Wilimas J. A., Green A. A., Look A. T. Abnormalities of chromosomes 1 and 11 in Wilms' tumor. Cancer Genet Cytogenet. 1985 Jan 15;14(3-4):331–338. doi: 10.1016/0165-4608(85)90199-2. [DOI] [PubMed] [Google Scholar]
  19. Drummond I. A., Madden S. L., Rohwer-Nutter P., Bell G. I., Sukhatme V. P., Rauscher F. J., 3rd Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 1992 Jul 31;257(5070):674–678. doi: 10.1126/science.1323141. [DOI] [PubMed] [Google Scholar]
  20. Ekblom P. Developmentally regulated conversion of mesenchyme to epithelium. FASEB J. 1989 Aug;3(10):2141–2150. doi: 10.1096/fasebj.3.10.2666230. [DOI] [PubMed] [Google Scholar]
  21. Francke U., Holmes L. B., Atkins L., Riccardi V. M. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 1979;24(3):185–192. doi: 10.1159/000131375. [DOI] [PubMed] [Google Scholar]
  22. Gashler A. L., Bonthron D. T., Madden S. L., Rauscher F. J., 3rd, Collins T., Sukhatme V. P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10984–10988. doi: 10.1073/pnas.89.22.10984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gerald W. L., Gramling T. S., Sens D. A., Garvin A. J. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor. Am J Pathol. 1992 May;140(5):1031–1037. [PMC free article] [PubMed] [Google Scholar]
  24. Gessler M., König A., Bruns G. A. The genomic organization and expression of the WT1 gene. Genomics. 1992 Apr;12(4):807–813. doi: 10.1016/0888-7543(92)90313-h. [DOI] [PubMed] [Google Scholar]
  25. Gessler M., König A., Moore J., Qualman S., Arden K., Cavenee W., Bruns G. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome. Genes Chromosomes Cancer. 1993 Jul;7(3):131–136. doi: 10.1002/gcc.2870070304. [DOI] [PubMed] [Google Scholar]
  26. Gessler M., Thomas G. H., Couillin P., Junien C., McGillivray B. C., Hayden M., Jaschek G., Bruns G. A. A deletion map of the WAGR region on chromosome 11. Am J Hum Genet. 1989 Apr;44(4):486–495. [PMC free article] [PubMed] [Google Scholar]
  27. Giannoukakis N., Deal C., Paquette J., Goodyer C. G., Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet. 1993 May;4(1):98–101. doi: 10.1038/ng0593-98. [DOI] [PubMed] [Google Scholar]
  28. Golden W. L., Sudduth K. W., Lovell M. A. Clonal evolution of a Wilms' tumor. Cancer Genet Cytogenet. 1992 May;60(1):102–104. doi: 10.1016/0165-4608(92)90245-4. [DOI] [PubMed] [Google Scholar]
  29. Haber D. A., Buckler A. J., Glaser T., Call K. M., Pelletier J., Sohn R. L., Douglass E. C., Housman D. E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 1990 Jun 29;61(7):1257–1269. doi: 10.1016/0092-8674(90)90690-g. [DOI] [PubMed] [Google Scholar]
  30. Haber D. A., Sohn R. L., Buckler A. J., Pelletier J., Call K. M., Housman D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9618–9622. doi: 10.1073/pnas.88.21.9618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Haber D. A., Timmers H. T., Pelletier J., Sharp P. A., Housman D. E. A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6010–6014. doi: 10.1073/pnas.89.13.6010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Henry I., Bonaiti-Pellié C., Chehensse V., Beldjord C., Schwartz C., Utermann G., Junien C. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature. 1991 Jun 20;351(6328):665–667. doi: 10.1038/351665a0. [DOI] [PubMed] [Google Scholar]
  33. Henry I., Grandjouan S., Couillin P., Barichard F., Huerre-Jeanpierre C., Glaser T., Philip T., Lenoir G., Chaussain J. L., Junien C. Tumor-specific loss of 11p15.5 alleles in del11p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci U S A. 1989 May;86(9):3247–3251. doi: 10.1073/pnas.86.9.3247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Henry I., Hoovers J., Barichard F., Berthéas M. F., Puech A., Prieur F., Gessler M., Bruns G., Mannens M., Junien C. Pericentric intrachromosomal insertion responsible for recurrence of del(11)(p13p14) in a family. Genes Chromosomes Cancer. 1993 May;7(1):57–62. doi: 10.1002/gcc.2870070110. [DOI] [PubMed] [Google Scholar]
  35. Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature. 1987 Sep 17;329(6136):219–222. doi: 10.1038/329219a0. [DOI] [PubMed] [Google Scholar]
  36. Huff V., Miwa H., Haber D. A., Call K. M., Housman D., Strong L. C., Saunders G. F. Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am J Hum Genet. 1991 May;48(5):997–1003. [PMC free article] [PubMed] [Google Scholar]
  37. Huff V., Reeve A. E., Leppert M., Strong L. C., Douglass E. C., Geiser C. F., Li F. P., Meadows A., Callen D. F., Lenoir G. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor. Cancer Res. 1992 Nov 1;52(21):6117–6120. [PubMed] [Google Scholar]
  38. Kaneko Y., Kondo K., Rowley J. D., Moohr J. W., Maurer H. S. Further chromosome studies on Wilms' tumor cells of patients without aniridia. Cancer Genet Cytogenet. 1983 Oct;10(2):191–197. doi: 10.1016/0165-4608(83)90124-3. [DOI] [PubMed] [Google Scholar]
  39. Knudson A. G., Jr Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 1985 Apr;45(4):1437–1443. [PubMed] [Google Scholar]
  40. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Knudson A. G., Jr, Strong L. C. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb;48(2):313–324. [PubMed] [Google Scholar]
  42. Koufos A., Grundy P., Morgan K., Aleck K. A., Hadro T., Lampkin B. C., Kalbakji A., Cavenee W. K. Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet. 1989 May;44(5):711–719. [PMC free article] [PubMed] [Google Scholar]
  43. Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Housman D., Jaenisch R. WT-1 is required for early kidney development. Cell. 1993 Aug 27;74(4):679–691. doi: 10.1016/0092-8674(93)90515-r. [DOI] [PubMed] [Google Scholar]
  44. Lee T. C., Zhang Y., Aston C., Hintz R., Jagirdar J., Perle M. A., Burt M., Rom W. N. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res. 1993 Jun 15;53(12):2858–2864. [PubMed] [Google Scholar]
  45. Lemaire P., Vesque C., Schmitt J., Stunnenberg H., Frank R., Charnay P. The serum-inducible mouse gene Krox-24 encodes a sequence-specific transcriptional activator. Mol Cell Biol. 1990 Jul;10(7):3456–3467. doi: 10.1128/mcb.10.7.3456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Lewis W. H., Yeger H., Bonetta L., Chan H. S., Kang J., Junien C., Cowell J., Jones C., Dafoe L. A. Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms tumor. Genomics. 1988 Jul;3(1):25–31. doi: 10.1016/0888-7543(88)90154-1. [DOI] [PubMed] [Google Scholar]
  47. Little M. H., Dunn R., Byrne J. A., Seawright A., Smith P. J., Pritchard-Jones K., van Heyningen V., Hastie N. D. Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogene. 1992 Apr;7(4):635–641. [PubMed] [Google Scholar]
  48. Little M. H., Prosser J., Condie A., Smith P. J., Van Heyningen V., Hastie N. D. Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4791–4795. doi: 10.1073/pnas.89.11.4791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Little M. H., Williamson K. A., Mannens M., Kelsey A., Gosden C., Hastie N. D., van Heyningen V. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet. 1993 Mar;2(3):259–264. doi: 10.1093/hmg/2.3.259. [DOI] [PubMed] [Google Scholar]
  50. Madden S. L., Cook D. M., Morris J. F., Gashler A., Sukhatme V. P., Rauscher F. J., 3rd Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science. 1991 Sep 27;253(5027):1550–1553. doi: 10.1126/science.1654597. [DOI] [PubMed] [Google Scholar]
  51. Madden S. L., Cook D. M., Rauscher F. J., 3rd A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene. 1993 Jul;8(7):1713–1720. [PubMed] [Google Scholar]
  52. Mannens M., Slater R. M., Heyting C., Bliek J., de Kraker J., Coad N., de Pagter-Holthuizen P., Pearson P. L. Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet. 1988 Dec;81(1):41–48. doi: 10.1007/BF00283727. [DOI] [PubMed] [Google Scholar]
  53. Maw M. A., Grundy P. E., Millow L. J., Eccles M. R., Dunn R. S., Smith P. J., Feinberg A. P., Law D. J., Paterson M. C., Telzerow P. E. A third Wilms' tumor locus on chromosome 16q. Cancer Res. 1992 Jun 1;52(11):3094–3098. [PubMed] [Google Scholar]
  54. McDowell H., Howard P., Martin J., Hart C., Crampton J. Chromosome 1 studies in Wilms' tumor. Cancer Genet Cytogenet. 1989 Dec;43(2):203–209. doi: 10.1016/0165-4608(89)90031-9. [DOI] [PubMed] [Google Scholar]
  55. Mehta M. P., Bastin K. T., Wiersma S. R. Treatment of Wilms' tumour. Current recommendations. Drugs. 1991 Nov;42(5):766–780. doi: 10.2165/00003495-199142050-00004. [DOI] [PubMed] [Google Scholar]
  56. Miwa H., Beran M., Saunders G. F. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia. 1992 May;6(5):405–409. [PubMed] [Google Scholar]
  57. Miwa H., Tomlinson G. E., Timmons C. F., Huff V., Cohn S. L., Strong L. C., Saunders G. F. RNA expression of the WT1 gene in Wilms' tumors in relation to histology. J Natl Cancer Inst. 1992 Feb 5;84(3):181–187. doi: 10.1093/jnci/84.3.181. [DOI] [PubMed] [Google Scholar]
  58. Morris J. F., Madden S. L., Tournay O. E., Cook D. M., Sukhatme V. P., Rauscher F. J., 3rd Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene. 1991 Dec;6(12):2339–2348. [PubMed] [Google Scholar]
  59. Ogawa O., Eccles M. R., Szeto J., McNoe L. A., Yun K., Maw M. A., Smith P. J., Reeve A. E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 1993 Apr 22;362(6422):749–751. doi: 10.1038/362749a0. [DOI] [PubMed] [Google Scholar]
  60. Ogawa O., Eccles M. R., Yun K., Mueller R. F., Holdaway M. D., Reeve A. E. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum Mol Genet. 1993 Feb;2(2):203–204. doi: 10.1093/hmg/2.2.203. [DOI] [PubMed] [Google Scholar]
  61. Ohlsson R., Nyström A., Pfeifer-Ohlsson S., Töhönen V., Hedborg F., Schofield P., Flam F., Ekström T. J. IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet. 1993 May;4(1):94–97. doi: 10.1038/ng0593-94. [DOI] [PubMed] [Google Scholar]
  62. Pal N., Wadey R. B., Buckle B., Yeomans E., Pritchard J., Cowell J. K. Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene. 1990 Nov;5(11):1665–1668. [PubMed] [Google Scholar]
  63. Pavletich N. P., Pabo C. O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science. 1991 May 10;252(5007):809–817. doi: 10.1126/science.2028256. [DOI] [PubMed] [Google Scholar]
  64. Pelletier J., Bruening W., Kashtan C. E., Mauer S. M., Manivel J. C., Striegel J. E., Houghton D. C., Junien C., Habib R., Fouser L. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell. 1991 Oct 18;67(2):437–447. doi: 10.1016/0092-8674(91)90194-4. [DOI] [PubMed] [Google Scholar]
  65. Pelletier J., Bruening W., Li F. P., Haber D. A., Glaser T., Housman D. E. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature. 1991 Oct 3;353(6343):431–434. doi: 10.1038/353431a0. [DOI] [PubMed] [Google Scholar]
  66. Pritchard-Jones K., Fleming S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene. 1991 Dec;6(12):2211–2220. [PubMed] [Google Scholar]
  67. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C., Bard J., Buckler A., Pelletier J., Housman D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990 Jul 12;346(6280):194–197. doi: 10.1038/346194a0. [DOI] [PubMed] [Google Scholar]
  68. Rainier S., Johnson L. A., Dobry C. J., Ping A. J., Grundy P. E., Feinberg A. P. Relaxation of imprinted genes in human cancer. Nature. 1993 Apr 22;362(6422):747–749. doi: 10.1038/362747a0. [DOI] [PubMed] [Google Scholar]
  69. Rauscher F. J., 3rd, Morris J. F., Tournay O. E., Cook D. M., Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science. 1990 Nov 30;250(4985):1259–1262. doi: 10.1126/science.2244209. [DOI] [PubMed] [Google Scholar]
  70. Reeve A. E., Eccles M. R., Wilkins R. J., Bell G. I., Millow L. J. Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature. 1985 Sep 19;317(6034):258–260. doi: 10.1038/317258a0. [DOI] [PubMed] [Google Scholar]
  71. Reeve A. E., Sih S. A., Raizis A. M., Feinberg A. P. Loss of allelic heterozygosity at a second locus on chromosome 11 in sporadic Wilms' tumor cells. Mol Cell Biol. 1989 Apr;9(4):1799–1803. doi: 10.1128/mcb.9.4.1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Rose E. A., Glaser T., Jones C., Smith C. L., Lewis W. H., Call K. M., Minden M., Champagne E., Bonetta L., Yeger H. Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell. 1990 Feb 9;60(3):495–508. doi: 10.1016/0092-8674(90)90600-j. [DOI] [PubMed] [Google Scholar]
  73. Schroeder W. T., Chao L. Y., Dao D. D., Strong L. C., Pathak S., Riccardi V., Lewis W. H., Saunders G. F. Nonrandom loss of maternal chromosome 11 alleles in Wilms tumors. Am J Hum Genet. 1987 May;40(5):413–420. [PMC free article] [PubMed] [Google Scholar]
  74. Scott J., Cowell J., Robertson M. E., Priestley L. M., Wadey R., Hopkins B., Pritchard J., Bell G. I., Rall L. B., Graham C. F. Insulin-like growth factor-II gene expression in Wilms' tumour and embryonic tissues. Nature. 1985 Sep 19;317(6034):260–262. doi: 10.1038/317260a0. [DOI] [PubMed] [Google Scholar]
  75. Sukhatme V. P., Cao X. M., Chang L. C., Tsai-Morris C. H., Stamenkovich D., Ferreira P. C., Cohen D. R., Edwards S. A., Shows T. B., Curran T. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 1988 Apr 8;53(1):37–43. doi: 10.1016/0092-8674(88)90485-0. [DOI] [PubMed] [Google Scholar]
  76. Tadokoro K., Fujii H., Ohshima A., Kakizawa Y., Shimizu K., Sakai A., Sumiyoshi K., Inoue T., Hayashi Y., Yamada M. Intragenic homozygous deletion of the WT1 gene in Wilms' tumor. Oncogene. 1992 Jun;7(6):1215–1221. [PubMed] [Google Scholar]
  77. Telerman A., Dodemont H., Degraef C., Galand P., Bauwens S., Van Oostveldt P., Amson R. B. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene. Oncogene. 1992 Dec;7(12):2545–2548. [PubMed] [Google Scholar]
  78. Wadey R. B., Pal N., Buckle B., Yeomans E., Pritchard J., Cowell J. K. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene. 1990 Jun;5(6):901–907. [PubMed] [Google Scholar]
  79. Wang Z. Y., Madden S. L., Deuel T. F., Rauscher F. J., 3rd The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem. 1992 Nov 5;267(31):21999–22002. [PubMed] [Google Scholar]
  80. Werner H., Re G. G., Drummond I. A., Sukhatme V. P., Rauscher F. J., 3rd, Sens D. A., Garvin A. J., LeRoith D., Roberts C. T., Jr Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5828–5832. doi: 10.1073/pnas.90.12.5828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Williams J. C., Brown K. W., Mott M. G., Maitland N. J. Maternal allele loss in Wilms' tumour. Lancet. 1989 Feb 4;1(8632):283–284. doi: 10.1016/s0140-6736(89)91300-7. [DOI] [PubMed] [Google Scholar]
  82. Yeger H., Cullinane C., Flenniken A., Chilton-MacNeil S., Campbell C., Huang A., Bonetta L., Coppes M. J., Thorner P., Williams B. R. Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes. Cell Growth Differ. 1992 Dec;3(12):855–864. [PubMed] [Google Scholar]
  83. Zhang Y., Tycko B. Monoallelic expression of the human H19 gene. Nat Genet. 1992 Apr;1(1):40–44. doi: 10.1038/ng0492-40. [DOI] [PubMed] [Google Scholar]
  84. van Heyningen V., Bickmore W. A., Seawright A., Fletcher J. M., Maule J., Fekete G., Gessler M., Bruns G. A., Huerre-Jeanpierre C., Junien C. Role for the Wilms tumor gene in genital development? Proc Natl Acad Sci U S A. 1990 Jul;87(14):5383–5386. doi: 10.1073/pnas.87.14.5383. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES